Several analysts have recently updated their ratings and price targets for MEI Pharma (NASDAQ: MEIP): 2/14/2024 – MEI Pharma had its price target lowered by analysts at Stifel Nicolaus from $8.00 to $7.00. They now have a “hold” rating on the stock. 2/13/2024 – MEI Pharma was downgraded by analysts at StockNews.com from a “buy” […]